Variation of ER status between primary and metastatic breast cancer and relationship to p53 expression

Steroids

Volumn 66, Issue 12, 2001, Pages 905-910

  Zheng, Wei Qiang ^a   Lu, Jian ^b   Zheng, Jian Ming ^a   Hu, Feng Xian ^a   Ni, Chan Rong ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Breast neoplasm; ER mRNA; Estrogen receptor; Immunohistochemistry; In situ hybridization; p53

Indexed keywords

DIGOXIGENIN; ESTROGEN RECEPTOR; HORMONE; MONOCLONAL ANTIBODY; PROTEIN P53; RECEPTOR ANTIBODY;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; TREATMENT OUTCOME;

BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHATIC METASTASIS; MIDDLE AGED; MUTATION; RECEPTORS, ESTROGEN; RNA, MESSENGER;

EID: 0035167302     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(01)00121-0     Document Type: Article

References (24)

1. Estrogen receptor in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA
2. The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer
3. Endocrine resistance in advanced breast cancer
4. Role of estrogen receptor variants in the development of hormone resistance in breast cancer
5. Comparison of estrogen receptor levels in primary and regional metastatic carcinoma of the breast
6. The p53 tumour suppressor gene
7. Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis?
8. p53 immunoreactivity in inflammatory and neoplastic diseases of the uterine cervix
9. p53 protein accumulation predicts poor response to tamoxifen therapy of patients with recurrent breast cancer
10. Pathological prognostic factors in breast cancer. 1. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
11. Estrogen receptors in human breast cancer: An overview
12. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer
13. Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer
14. Estrogen receptor status determined by immunohistochemistry is superior to biochemical ligand-binding assay for evaluating breast cancer patients
15. Estrogen receptors: Prognostic significance in breast cancer
16. Estrogen receptor: A prognostic feature in breast cancer
17. Changes in multiple or sequential estrogen receptor determinations in breast cancer
18. The p53 proto-oncogene can act as a suppressor of transformation
19. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation
20. p53 gene mutations and steroid receptor status in breast cancer, clinicopathologic correlations and prognostic assessment
21. Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancer
22. An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis
23. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer
24. Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 breast cancer cells